Griffin Funding Sets Sights on $3B Non-QM Landmark With New SVP of Growth, John Jones

Leadership promotion

Big moves are unfolding in the non-QM lending world, and they’re coming from one of the industry’s most watched innovators: Griffin Funding. The company announced that John Jones—known for his ability to scale organizations with precision—has officially stepped into the role of Senior Vice President of Growth and EOS Integrator.

A Leadership Shift Aimed at Massive Expansion

After serving as Griffin Funding’s fractional integrator and COO since April 2025, Jones will now take the reins full-time beginning December 1. According to CEO Bill Lyons, Jones has already brought “tremendous structure and clarity” to the operation—a strong endorsement as the company gears up for its next chapter.

And that next chapter is bold: driving Griffin Funding to $3 billion in annual non-QM loan volume by 2030.

What Jones Will Lead Next

Jones’s new mission focuses on strengthening leadership, boosting production efficiency, expanding into new markets, and optimizing both sales and operational channels. In short, he’s becoming the architect behind Griffin’s next phase of smart, scalable growth.

As Chloe Shubin, VP of Strategy, puts it: “John’s impact is felt across every department… He helps align strategy with execution.

A Growing Footprint Backed by Solid Numbers

Griffin Funding already operates active offices in San Diego, Irvine, and Scottsdale. With $72.5 million in warehouse line liquidity powering its lending engine and $346.3 million in closed deal volume recorded as of November 17, the company appears to be positioned for a breakout decade ahead.

For readers across real estate, mortgage, finance, and compliance-driven professions, this move is absolutely one to watch. Leadership shifts like this often trigger new innovation, new hiring waves, and fresh professional development opportunities throughout the industry.

And if you’re looking to strengthen your own professional edge in high‑growth fields like real estate, mortgage, insurance, finance, or medical licensing, Cameron Academy is here to help you build the skills, certifications, and licenses that move careers forward.

More Articles

Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!

Gene Editing: A Promising Frontier in Biotechnology

Gene editing technology is swiftly emerging as a transformative force in both healthcare and agriculture, particularly through tools like CRISPR-Cas9, which offer precise methods to modify genes and promise to revolutionize treatment for genetic disorders, cancer, and infectious diseases.

Empowering the Gig Economy: AXA’s Tailored Protection

Angela Wong, Chief Marketing and Customer Officer at AXA Hong Kong & Macau, underscores the critical need for comprehensive insurance solutions for gig workers.

By |November 24, 2024|Categories: Article, Business, Insurance|Tags: , |0 Comments

Ethical Deployment of AI in Healthcare: AMA’s Guiding Strategies

The AMA highlights that AI's integration must be guided by the fundamental principles of medical ethics: patient autonomy, beneficence, nonmaleficence, and justice.

By |November 24, 2024|Categories: Article, Healthcare, Technology Ethics|Tags: , |0 Comments

AI’s Role in Revolutionizing Medical Education

AI, which simulates human intelligence, is reshaping various sectors, particularly healthcare. The ability to perform complex tasks, such as diagnostics and personalized healthcare, is no longer confined to human capabilities alone.

By |November 23, 2024|Categories: Article, Education, Technology|Tags: , |0 Comments

AI Chatbots in Chronic Disease Diagnosis

A recent study published in Nature on July 25, 2024, unveils a cutting-edge chatbot named Chat Ella, designed to assist in the diagnosis of chronic diseases.

Revolutionizing Genetic Research with CRISPR-Cas Technology

CRISPR-Cas technology is not just a tool but a gateway to understanding the genetic influences on diseases.